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WOMEN'S HEAL TH RESEARCH IN CANADA: 
FEMINIST CHANGE IN A MURKY ZONE OF LAW, 
MEDICINE AND POLITICS 
ABSTRACT 
The general aim of this paper is to explore the relationship between 
law and the potential for social change in the context of women's health. 
More specifically, I will critically examine the arguments made by 
Canadian feminists about the need for change in the ways that health 
research is stmctured and carried out in this countiy, particularly with 
respect to the generation of knowledge about women's health. 
Part one of this analysis examines the nature and extent of the 
problem of gender-biased research. Itis followed by an overview of the 
regulatory framework within which health research is cun-ently con-
ducted in Canada. The third part of this discussion provides a feminist 
analysis of the major arguments raised by those who seek to maintain 
the exclusionary status quo. Part four reflects upon the impact of politi-
cal action for change taken by women's health activists. Recognizing 
that Canadian feminists have, to date, been more successful in influenc-
ing change through public activism in the political arena than through 
efforts to work within the dominant research institutions, the paper con-
cludes with a brief assessment of the prospects for legislative intervention. 
I. INTRODUCTION 
Striking parallels exist between the histories of the Western institu-
tions of law and medicine in te1ms of dominant underlying values and 
styles of discourse. Linear rationality and repeatability of results are key 
doctrines in the methodologies of both. Other shared features include an 
t Erin Skim1er graduated from the combined LLB/MHSA program at Dalhousie University 
in May 2001. 
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unquestioned commitment to positivism, a belief in objectivity and the 
ability to locate absolute truth through reasoned inquiry, the centrality of 
the rational individual, and views of civilized society as opposite to a 
violent state of nature. Similarly, one particular set of interests has been 
overwhelmingly represented throughout the rise of both institutions: the 
privileged social class of wealthy and highly educated white men. 
Many feminists contend that liberalism, which forms much of the 
ideological basis upon which both law and medicine are founded, has 
played a critical role in the construction of patriarchy in Western societies. 
Feminists have pointed to writings by influential liberal thinkers which 
espouse a fundamental belief that the female body is inherently pathologi-
cal, such that" ... women's bodies, women's minds, and women's natures 
are essentially and dangerously inferior to those of men."1 Women's 
unique reproductive capacity was central to this notion. 
The concept of women as other - distinct from and less natural than 
men - has been a powerful and enduring concept. For example, as 
recently as 1979 the Supreme Court of Canada ruled that a federal law 
distinguishing pregnant persons from non-pregnant persons did not 
constitute unequal treatment of women and men. Bliss v. Attorney-
General of Canada2 illustrates the extent to which social inequality and 
scientific notions of biological difference are inter-related in traditional, 
androcentric legal thinking: 
... [T]he Supreme Court used maleness as the standard against which 
pregnant women were compared. The absence of an analogous physi-
cal condition or equivalent life experience to pregnancy for men meant 
that there were not two similarly situated groups that could be com-
pared to determine whether there was equal or unequal treatment. In 
doing so, they used the male body as the inaiiiculate major premise 
and differential treatment and special burdens could be imposed on 
women without there being any formalistic 'inequality. ' 3 
1 K. Pauly Morgan, "Contested Bodies, Contested Knowledges: Women, Health, and the 
Politics of Medicalization" in The Politics of Women's Health; Exploring Agency and Au-
tonomy (Philadelphia: Temple University Press, 1998) 83 at 102 [hereinafter Exploring 
Agency and Autonomy]. 
2 [1979] 1 S.C.R. 183. This approach to equality was overturned by the Supreme Court of 
Canada in Laiv Society of British Columbia et al. v. Andrews et al., [1989] 1 S.C.R. 143 
[hereinafter Law Society]. 
3 S. Martin, "The Control of Women through Gender-Biased Laws on Human Reproduc-
tion" in R. Devlin, ed., Canadian Perspectives on Legal Theo1y (Toronto: Emond-Montgom-
ery, 1991) 291 at 297. 
184 - DALHOUSIE JOURNAL OF LEGAL STUDIES 
This formalistic approach to equality rights is central to the classic 
liberal vision of a fair society in which, as the Bliss case suggests, male 
experience is held to be the norm. 
Fortunately, Canadian courts have now rejected formal equality as 
incompatible with social values in the Charter era and a more substan-
tive concept of equality has emerged.4 Nonetheless, the idea that all 
individuals should be treated similarly, regardless of differing social 
realities, remains an appealing, deeply-rooted principle in this society 
where a liberal-democratic ethos is the dominant paradigm. Subse-
quently, and to a certain degree inescapably, liberalism tempers gender 
relations in all Canadian social contexts. The health care arena is no 
exception. 
The general theory advanced by many feminists is that sexist pre-
sumptions are an inherent feature of traditional medical scientific dis-
course and continue to exe1i significant influence upon decision-making 
in health research. Many of the questions and problems historically 
identified as medically important (with the critical exception of female 
reproductive capacity), as well as the investigational approaches used to 
study those questions and problems, have tended to focus exclusively on 
the male half of the human species. A large knowledge gap exists as a 
result of this approach: comparatively less is known about women's 
health, beyond the limited scope of reproduction, than is known about 
men's experiences with health and disease. Consequently, women are 
frequently exposed to inappropriate, ineffective, and potentially danger-
ous medical interventions and information. 
My own analysis of the situation is that the feminist position on this 
apparent inequity has gained a large measure of public credence, which 
has been reflected in a variety of political successes. The prospect for 
meaningful systemic change towards more equitable research practices 
is heavily constrained, however, by structural features of the medico-
legal framework within which research is regulated in Canada. More 
paiiicularly, the lack of a cohesive regulatory regime means that ac-
countability for how public research monies are invested is highly 
diffuse; individual researchers, funding councils, and the phannaceuti-
cal industry essentially hold the reins in detennining the extent to which 
4 Law Society, supra note 2. 
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women's health concerns are reflected in the research agenda. At 
present, research regulation is a murky zone of law, medicine, and 
politics and the diffusion of accountability makes it exceedingly diffi-
cult to dispel widespread, deeply-rooted "scientific" myths about the 
concept of women's health and its social value in contributing to social 
equality. I propose that this state of affairs is highly incompatible with 
Canada's commitments to advancing women's equality and that legisla-
tive intervention is essential to overcoming the structural barriers to 
change. 
II. NATURE AND EXTENT OF THE PROBLEM OF 
EXCLUSIONARY RESEARCH PRACTICES 
'Women aren 't just asking/or pink walls, a warm speculum and kinder 
doctors.' In fact, we're not asking, at all. We are engaged in a political 
fight for shared knowledge, for collective power, for health, for bodily 
integrity - for ourselves, our communities, and our world. 5 
Calling attention to male-biased research norms is part of the 
broader women's health movement through which feminists seek to 
challenge the legitimacy and paternalism of institutionalized medical 
science. The dominant medical paradigm understands health to be sim-
ply the absence of disease. Feminists like Margaret Lock6 and Ruth 
Macklin7 are critical of this model and its view of human bodies as 
nan-ow entities whose health status is determined by nature-given physi-
ological and genetic features. Rooted in l 91h century reductionist theo-
ries of biology, the disease-based construct ignores the potential impact 
of social dynamics upon an individual's experiences with illness and 
health. Consequently, reproductive capacity is seen to be the only sub-
stantive difference leading to varying health experiences between men 
and women. This focus on disease fosters a competitive, highly 
5 Pauly Morgan, supra note 1 at 115 (citing P. Williams, "Sick of Dying: Neglect, 
Misinfonnation, and Gender Bias have Festered Unchecked in Women's Health Care" 
Homemaker's Maga:::ine (November/December 1996) 46 at 49.) 
6 "Situating Women in the Politics of Health" in Exploring Agency and Autonomy, supra 
note 1, 48. 
7 "Women's Health: an Ethical Perspective" (1993) 21:1 J. Law, Med. & Ethics. 23. 
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technologized race to locate, within the body, ultimate sources of dis-
ease causation in order to develop successful treatment interventions. 
There are enonnous financial stakes in the race to provide cures and halt 
disease progression. Thus, any attempt to uproot the disease model or 
cross-pollinate it with alternative models will face considerable resis-
tance. 
Feminists are not alone in pointing to the eITors inherent in the 
biomedical disease-based model of health. In 1981 the World Health 
Organization (WHO) enunciated a broader alternative concept known as 
the determinants model. Health was accordingly redefined as "a com-
plete state of physical, mental and social well-being, not simply the 
absence of disease or infinnity."8 Recognition of a political dimension 
to the relative health of individuals and social groups is a key aspect of 
the feminist divergence from the disease model of health. 
The gendered lines of oppression in societies are reflected in patterns 
of how women are treated by the health care system both as patients and 
as active participants, and the detenninants approach is expanded to 
include gender as a detemtinant of health. In much the same way, the 
marginalization that occurs through racism in Canadian society is an 
important health detern1inant. From the detenninants perspective, the 
experience of multiple discrimination in society will often be reflected 
in reduced health status among women of colour. In a significant depar-
ture from the traditional reproduction-centred view, feminism 
reconceptualizes women's health as involving " ... women's emotional, 
social, cultural, spiritual and physical well-being, and it is determined by 
the social, political and economic context of women's lives as well as by 
biology."9 Women-specific health information, generated through re-
search, is seen as critical to improving both the well-being and relative 
social equality of women. In addition to reconstructing the definition of 
health and calling for more info1mation to reflect women's health inter-
ests, feminists contend that traditional research methods themselves are 
:fundamentally biased. 
8 Ibid. at 24. 
9 National Forum on Health, "An Overview of Women's Health" in Canada Health 
Action: Building on the Legacy Vol. II (Ottawa: National Forum on Health) 3 (citing S. 
Phillips, "The Social Context of Women's Health: Goals and Objectives for Medical Educa-
tion" (February 1995) 154:4 Canadian Medical Association J. at 507) [hereinafter National 
Forum on Health]. 
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1. Manifestation of Gender Bias in Research 
According to feminist sociologist Margrit Eichler, bias against 
women as subjects in the research process manifests in four main ways: 
androcentrism; overgeneralization; gender insensitivity; and the use of 
double standards. 10 A review of international articles published in 1989 
by the New England Journal of Medicine found, using Eichler's frame-
work, that 80% of original research articles published in that year 
contained at least one fonn of gender bias. 11 
Androcentricity involves a presumptive reliance on the male para-
digm or male-centered world view, which most often means that women 
are consciously excluded from subject populations. This has the effect 
(intended or otherwise) of pre-emptively eliminating any potential find-
ings of difference in results between men and women. In so doing, 
women's different biological and social realities that impact on health 
status are rendered invisible. 
Overgeneralization of findings often follows from androcentric re-
search designs. In such instances, study results are presented in a tmiver-
sally applicable manner, while in fact it is unknown whether such is true 
because the study was conducted entirely on one gender (usually male). 
The double standard bias involves " ... evaluation, treatment, or mea-
surement of identical behaviours, traits, and situations by different 
means."12 One of the best known examples of this biased approach was 
seen in early findings from the Framingham Heart Study (a long-tenn 
continuous study started in 1948).13 Initially, researchers simply dis-
missed complaints of chest pain among female subjects as essentially 
harmless, in contrast to similar complaints by male subjects, which were 
deemed highly significant. The different treatment stemmed from the 
presumption that the male subjects were more likely than the female 
subjects to experience heart attacks and sudden death as a result of their 
10 L. Wallis, "Why a Cufficulum on Women's Health?" in A. Dan, ed., Reframing 
Women's Health: Multidisciplinary Research and Practice (Thousand Oaks, Calif.: Sage, 
1994) [hereinafter Reframing Women's Health]; also cited by Y. Lefebvre, Women's Health 
Research in Canada (Ottawa: Health Canada, 1996) (paper prepared for the Canada-USA 
Fornm on Women's Health). 
11 K. Williams & E. Borins, "Gender Bias in a Peer-Reviewed Medical Journal" (1993) 48 
J. American Med. Women's Assoc. 160 (cited by Lefebvre, ibid. at 6). 
12 Refi'aming Women's Health, supra note 11 at 19 
13 B. Healy, A New Prescription for Health; Getting the Best Medical Care in a Man's 
World (New York: Penguin, 1995) at 332-333. 
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chest pain. This was consistent with prevailing op1111ons that heart 
disease was a man's disease and that women were hypochondriacs. 
Subsequent research concluded, however, that women's chest pains are 
indeed indicative of very real, potentially dangerous heart conditions 
that are not typically seen in men. By applying a double standard to the 
early reports from research subjects, the Framingham researchers had 
essentially validated the existing myths by applying a "scientific proof' 
label. 
2. Pervasiveness of Bias in Canada 
As the New England Journal of Medicine study indicates, the extent 
to which gender bias pervades medical research is significant. While no 
parallel study has analyzed the contents of Canadian medical journals, 
gender biased research appears to be the nonn in this country. In 1994, 
the Advisory Committee on Women's Health to the Medical Research 
Council of Canada (MRC, the largest source of federal research fund-
ing) attempted to assess the extent to which it historically funded 
women's health research. Problems associated with data availability, 
definition of research designs, interpretation of findings, and unrecorded 
research activities made it clear that the MRC lacked the capacity to 
accurately review the gender dynamics of the research it had itself 
funded. 14 Interestingly, the MRC study detennined that roughly 5% of 
its funding was invested into women's health issues while a similar 
study of research funding led to the estimate that 7% of funding was 
directed towards men's health issues. As Lefebvre notes, "[t]hese fig-
ures of course imply that the remainder of the research funded is general 
neutral, which is probably inaccurate."15 Such findings suggest that 
gender insensitivity and other forms of bias exist in 88% ofMRC funded 
research. 
An impo1iant overall trend, moreover, is the fact that the vast major-
ity of funded research with an explicitly gendered approach focuses 
exclusively on reproductive matters. This reflects the pre-eminence of a 
reproduction-centered view of women's health. Analysis of research 
funded in 1994-95 by the National Health Research Development Pro-
gram (NHRDP) revealed that 70% of its total investment in women's 
14 Lefebvre, supra note 11 at 4-5. 
15 Lefebvre, supra note 11 at 6. 
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health issues went to reproductive studies, a broad category which 
included investigations into the health of newborn infants (a group 
which hardly fits into the category of 'women' at all). 
3. Implications for Women 
Generally, the impact of systemic marginalization of women in 
health research results in skewed treatment of some health problems and 
non-treatment of other concerns peculiar to women that have not been 
taken seriously by the health care establishment. 
Specific examples abound. In 1977-78, for instance, Canadian femi-
nists Leah Cohen (a social scientist) and Constance Backhouse (a law-
yer) identified the following disturbing patterns: 16 
• overmedication of women, particularly with mood-altering 
drngs, 
high rates of unnecessary surgeries on the women, in particular 
hysterectomies, breast surgery, and cesarean section births, 
estrogen replacement therapy targeted to women pathologized 
simply by virtue of going through menopause, 
• the frequency of crisis-oriented, technology-managed hospital 
births along with the absence of 'legitimate' alternatives such 
as home births, 
• suppressed information about the legality of abortion, hospital-
introduced delays and quotas, and restricted access to abo1iion 
services, and 
• negligence, avoidance, and trivialization of female rape victims 
by many physicians and health care professionals in emergency 
rooms. 
In 1998, Morgan contended that all of these patterns remain relevant 
concerns for Canadian women. 17 
Particular attention has been directed towards the situation of 
women as consumers of pharmaceutical products that have been tested 
only on male subjects in clinical trials. Despite the reasons suggesting 
16 "Women and Health: the Growing Controversy" 1:4 Can. Women's Studies 4-10 (cited 
by Morgan in Exploring Agency and Autonomy, supra note 1 at 83.) 
17 Exploring Agency and Autonomy, supra note 1. 
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that the conventional approach of testing drugs on men and generalizing 
the results to women may not be effective or appropriate, this has long 
been a widespread norm in Canada, 18 as elsewhere. As will be discussed 
below, some recent change has been seen at the federal level through 
introduction of the Guidelines on Inclusion of Women in Clinical Tri-
als19 under the auspices of the Food and Drugs Act.20 
Ill. REGULATION OF HUMAN EXPERIMENTATION IN CANADA 
In Canada, research involving human subjects is a quasi self-regulat-
ing industry that operates within a broad legal framework but under few 
specifically directed legislative provisions. Legal problems that arise in 
relation to questionable research practices can be addressed through a 
wide variety of mechanisms including courts of law (in cases where 
criminal charges are laid or civil actions for damages are pursued), 
public administrative bodies (research funding organizations, for in-
stance), or professional associations' internal disciplinary proceed-
ings. 21 In practice, administrative bodies make most decisions stem-
ming from potential legal quandaries and courts of law are used only in 
rare circumstances. The true locus of accountability for research involv-
ing human subjects in Canada is the individual research ethics boards 
(REBs) which are located in virtually every institution where research 
takes place. These committees do not look to laws but rather to codes of 
ethics, guidelines, and policy statements for guidance when dealing with 
quandaries in human research. 
1. Federal Statutory Provisions 
In an extremely general sense, the provisions of the Criminal Code22 
can be presumed to apply to researchers in the same general sense that 
18 National Fomm on Health, supra note 10 at 4. 
19 Inclusion of Women in Clinical Trials, Therapeutic Products Programme Guidelines 
(Ottawa: Health Canada, April 1997). 
20 R.S.C. 1985, c. F-27. 
21 Law Refonn Commission of Canada, Biomedical Experimentation Involving Human 
Subjects (Working Paper 61) (Ottawa: LRCC, 1989) at 7. 
22 R.S.C. 1985, c. C-46. 
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the criminal law applies to all Canadians.23 Verdun-Jones and Weisstub 
contend that researchers generally overlook the potential impact of 
criininal law in the research context and focus instead on avoiding civil 
litigation.24 No record has been found of criminal charges being laid 
under Canadian law against any researcher engaging in human experi-
mentation. The criminal law plays a minute and peripheral role in 
ensuring acceptable standards of research involving humans. 
The Law Reform Commission of Canada (LRCC) has recom-
mended a series of general amendments to the Criminal Code to make it 
more relevant to research activities. Among the numerous reasons cited 
as evidence of a need to amend the criminal law, the LRCC contends 
that there should " ... be consistency of thought and action ... " among 
provinces with respect to research standards of conduct.25 As this rea-
soning indicates, the lack of a national legal framework and correspond-
ing diffusion of authority for decision-making in human research has led 
to substantial variance in ethical norms across the country. 
The federal Food and Drugs Act26 and accompanying regulations 
gov em the introduction of new phannaceutical products to the Canadian 
consumer market. The legislative scheme specifies the conditions that 
manufacturers must meet prior to distributing new pharmaceutical prod-
ucts to researchers for clinical testing, which is a prerequisite to obtain-
ing government consideration for approval of a new drug.27 "These 
conditions provide a basic level of protection for experimental subjects 
who agree to have new chemical substances tested on them. The regula-
tions also stipulate that researchers must strictly monitor the use of 
medications, indicate any serious incidents resulting from their adminis-
tration, and submit a detailed report."28 
23 While generally applicable, the Criminal Code makes no express or implicit reference to 
medical research in any of provisions. Among other recommendations, the LRCC has said that 
"The Criminal Code should be amended by the addition of a provision which excludes from 
offences against bodily integrity those cases of non-therapeutic biomedical experimentation in 
which free and infonned consent is properly obtained and the risks incmred are not dispropor-
tionate to expected benefits.": LRCC, supra note 22 at 35. 
24 "The Regulation of Biomedical Research Experimentation in Canada: Developing an 
Effective Apparatus for the Implementation of Ethical Principles in a Scientific Milieu" 
(1996-97) 28:2 Ottawa L.R. 297 at 305. 
25 LRCC, supra, note 22 at 59. 
26 Supra note 21. 
27 LRCC, supra note 22 at 12. 
28 LRCC, supra note 22. 
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Canada's only formal regulatory statement mandating the inclusion 
of women in any research context operates under the authority of the 
Food and Drugs Act and Regulations.29 In April of 1997 Health 
Canada's Therapeutic Products Programme (TPP - also known as the 
Drugs Directorate), which administers and evaluates new drug submis-
sions from industry, established Guidelines on Inclusion of Women in 
Clinical Trials. The Guidelines establish that sponsors of clinical drug 
trials must enroll both men and women " ... in the same trials in numbers 
adequate to allow detection of clinically significant sex-related differ-
ences in drug response."30 Where significant differences are found to 
exist, researchers will be required to develop gender-specific prescrib-
ing infonnation and warnings before the drug can be approved for 
marketing. While there are no formal penalties for failure to adhere to 
the Guidelines, certain administrative incentives within the TPP encour-
age compliance among drug trial sponsors: "It's in their best interest as 
the review can take much longer if we ask them for infonnation they 
don't have on file or better yet, in their submission."31 
The creation and implementation of these Guidelines within the 
Food and Drugs Act regulatory scheme is a significant development and 
is largely attributable to the advocacy work of women's health activ-
ists. 32 It is important to appreciate, however, that it operates exclusively 
in relation to government approval of new pharmaceutical products -
which is only one feature of the much larger research landscape. 
2. Provincial Provisions 
Interestingly, despite an apparently high level of anxiety within the 
research c01mnunity about the potential for private action,33 Canadian 
casebooks have reported very few civil actions for damages incurred in 
29 LRCC, supra note 22. 
30 Supra, note 20 at 2. Note, however, the subsequent proviso: "In some cases, however, it 
may be appropriate to conduct studies in a single sex (e.g., to evaluate the effects of phases of 
the menstrual cycle on drug response). 
31 A. Goldstein, Health Canada (Therapeutic Products Programme) personal communica-
tion, October 26, 1999 (on file with author). 
32 F. Baylis, J. Downie & S. Shetwin, "Reframing Research Involving Humans" in 
Exploring Agency and Autonomy, supra note l at 238. 
33 Verdun-Jones & Weisstub, supra note 25; V. Me1ion, "The Exclusion of Pregnant, 
Pregnable, and Once-Pregnable People (a.k.a. Women) from Biomedical Research" (1993) 
XIX:4 Am. J. Law & Med. 369 at 400. 
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the course of research. Of the small number that are reported, only two 
arose in the direct context of fonnal research projects;34 several other 
cases relate to damages arising where practitioners have administered 
innovative or novel treatments that the professional mainstream viewed 
as untested and unsound. 35 In all instances, the primary issues related to 
the information provided by the researcher prior to the participant's 
decision to consent. 
From the caselaw, it is clear that the relevant standard of disclosure 
increases sharply when a medical intervention is deemed to have a 
strongly experimental component. In cases where the intervention has 
no intended potential direct to the participant (i.e. the intervention is 
"non-therapeutic"), the participant's consent will not be held as valid 
unless it was granted after all risks, no matter how remote, were dis-
closed. 36 This is, however, virtually all the information provided by 
Canadian caselaw regarding the legal duties owed by medical research-
ers in respect to prospective research subjects. 
The province of Quebec is the only jurisdiction in Canada to have 
enacted specific legislative provisions regulating activities relating to 
human experimentation. In response to quandaries arising in conjunc-
tion with early heart transplantation procedures, sections 18 to 25 were 
added to the chapter on "Enjoyment of Civil Rights" in the Civil Code 
(CCQ). Like the common law elsewhere in Canada, these provisions 
held that the major legal requirements for research on humans were that 
the subjects provide free and infonned consent and that the risks ofhann 
must not outweigh the anticipated benefits of participation. 37 Unlike the 
common law, however, the CCQ goes further and establishes specific 
requirements for research involving children and adults who lack capac-
ity to consent.38 These provisions further provide a statutory basis of 
authority for institutional research ethics boards to judge the ethical 
soundness of research activities in the province of Quebec. 
34 Halushka v. University of Saskatchewan et al. (1965), 53 D.L.R. (2d) 436 (Sask. C.A.) 
[hereinafter Halushka]; Weiss v. Solomon (1989), 48 C.C.L.T. 280 (Que. S.C.) [hereinafter 
Weiss]. · 
35 OJ1derma11 v. Ringrose (1978), 89 D.L.R. (3d) 32 (Alta S.C.); Zimmer v. Ringrose 
(1981), 28 A.R. 69 (C.A.); Coughlin v. Kunt:: (1987), 17 B.C.L.R. (2d) 365 (S.C.) 
36 Halushka, supra note 35; Weiss, supra note 34. 
37 LRCC, supra note 22 at 13. 
38 Art. 21 C.C.Q. 
39 Verdun-Jones & Weisstub, supra, note 25 at 317. 
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3. Research Ethics Boards and the Ethics Review Process 
Outside of Quebec, REBs do not operate under any enabling legisla-
tion but rather under the by-laws and policies of the hospitals, universi-
ties and other organizations in which REBs are housed. REBs " ... have 
no independent power to require that research protocols involving hu-
man subjects be submitted to them for prior approval."39 Public funding 
agency rules provide the most compelling practical source of authority 
for the REB role in research review in Canada. The Canadian Institutes 
for Health Research (CIHR, formerly the Medical Research Council of 
Canada), the Social Sciences and Humanities Research Council 
(SSHRC), and the Natural Sciences and Engineering Research Council 
of Canada (NSERC) are the country's largest sources of public funding 
for research in those respective fields. They stipulate that they will only 
fund research initiatives that are approved by an REB in an institution 
that has certified compliance with the Tri-Council Policy Statement: 
Ethical Conduct for Research Involving Humans. 40 
The general procedure for ethical review is similar in public institu-
tion-based REBs throughout Canada.41 Before a researcher commences 
research activities on human subjects, he or she first submits a research 
protocol describing the project's proposed purpose, methodology, and 
safety precautions to the REB of the institution or facility where the 
research will take place. After an ethical and scientific review is com-
pleted, the REB typically approves the protocol, approves it with speci-
fied modifications, or disallows it altogether.42 A 1995 study found that 
among the one hundred REBs associated with medical schools in 
Canada, all approve most protocols submitted for review and request 
only minor modifications.43 While the terms of reference of many REBs 
indicate a responsibility for on-going monitoring, the reality is that due 
to intense resource constraints, the monitoring function has traditionally 
40 Medical Research Council of Canada, Natural Sciences and Engineering Research 
Council of Canada, Social Sciences and Humanities Research Council of Canada, (Ottawa: 
Agency, 1998) at i-1 [hereinafter Tri-Council Policy Statement]. 
41 F. Baylis et al. eds., Health Care Ethics in Canada (Toronto: Harcomi Brace, 1995) at 322. 
42 Ibid. 
43 The NCBHR study found that 22% of submitted protocols were approved as first 
presented, 75% were approved with minor modifications, and 3% were rejected outright (in 
Verdun-Jones & Weisstub, supra note 25 at 322). 
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been often minimal or non-existent.44 This pattern should change, how-
ever, as the Tri-Council Policy Statement now expressly requires con-
tinuing review processes for research projects that are over one-year in 
duration and those that are seen to pose significant risks.45 
Numerous critics have questioned the ability of this model of moni-
toring to ensure that socially acceptable standards of conduct are upheld 
in research involving human subjects. A 1995 report by the National 
Council on Bioethics in Human Research (NCBHR) found that Cana-
dian REBs exercised review powers over almost all of the research 
initiatives being undertaken within their host institutions. The NCBHR 
repo1t further found that the existing review model is under-inclusive, 
however, in that it provides no assurance that research outside the scope 
of an REB's institutional authority will be reviewed for consistency with 
acceptable standards of conduct.46 There is no formal requirement that 
privately-funded research conducted outside of hospitals and universi-
ties be subject to ethics review or, moreover, be required to conform 
with accepted ethical nonns. 
Further questions about the effectiveness of this model relate to the 
sanctions that can be imposed for non-compliance with REB recommen-
dations. Given the lack of statut01y authority, the primary sanctions 
available are withholding of grant monies and denial of opportunity to 
publish in some international medical journals.47 The Law Reform 
Commission has spoken on this point as well, positing that in addition to 
amending the Criminal Code,48 the Parliament of Canada should enact 
general legislation on human research that prescribes state-sanctioned 
penalties for non-compliance.49 Furthermore, the Tri-Council Policy 
Statement requires institutions to vest their REBs with authority to 
withdraw initial approval and effectively halt research projects when it 
is detennined that unethical practices are occmTing. 50 
44 Verdun-Jones & Weisstub, supra note 25 at 325. 
45 Tri-Council Policy Statement, supra note 41 at 1.10. 
46 Verdun-Jones & Weisstub, supra note 25 at 320. 
47 M. Fox, "Research Bodies: Feminist Perspectives on Clinical Research" in S. Sheldon & 
M. Thomson, eds., Feminist Perspectives on Health Care Law (London: Cavendish, 1998) 
115 at 120-121 [hereinafter: Feminist Perspectives on Health Care Law]; Verdun-Jones & 
Weisstub, supra note 25 at 327. 
48 Supra note 23. 
49 LRCC, supra note 22 at 59. 
50 Tri-Council Policy Statemellt, supra note 41 at A1i. 1.2. 
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Another set of concerns surround the dual function most REBs serve 
in reviewing and assessing the soundness of both the scientific and 
ethical dimensions of proposed research projects. The main problem is 
that REBs have generally been "dominated by scientists and research-
ers, even though the fundamental ethical issues facing the REBs cannot 
be resolved by applying an exclusively scientific or technological exper-
tise. "51 The Tri-Council Policy Statement now mandates that REBs 
must have a broad membership, including both men and women. The 
minimum requirement is that each REB must have two members with 
research expertise, one who is "knowledgeable in ethics", one who is 
"knowledgeable in the relevant law", and one who is not affiliated with 
the REB' s institution but represents the community that is served by the 
institution.52 While this is an important development in theory, it is hard 
to ascertain its practical implications. In the past, where lay members 
have been encouraged to participate in ethics review, they have tended 
to be disempowered. Lacking research expertise, they have often been 
" ... dependent of researchers for information regarding research prac-
tices. "53 
4. Codes of Ethical Conduct in Human Research 
When ethical questions emerge in the course of a protocol evalua-
tion, REB members consult codified statements of ethically acceptable 
conduct. While some universities and research institutes have developed 
their own internal Codes or Guidelines, the most influential statements 
in Canada have emanated from the Medical Research Council (now 
CIHR). Unfortunately, with respect to the issues surrounding inclusion 
of women in research, the Tri-Council Policy Statement does more to 
create uncertainty than provide guidance. 
Research ethics codes reflect formal repudiation of medical 
science's tradition of exploiting oppressed peoples for research pur-
poses. For example, enslaved black women and poor white women were 
subjected to experimental gynaecological surgery in the United States in 
the nineteenth century, with one woman known to have survived thirty 
51 Verdun-Jones & Weisstub, supra note 25 at 323. 
52 Tri-Council Policy Statement, supra note 41 at 1.3. 
53 Fox, supra, note 48 at 121 
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separate invasive procedures. 54 While it was long customary for re-
searchers to use people in disadvantaged social classes for experimental 
purposes, international moral opprobrium was voiced for the first time 
during the post-war Nuremberg trials. 
Codifying the major principles of consensus has not, however, put 
an end to exploitative research practices. Subsequent transgressions 
gaining international notoriety since the Nuremberg Trials have in-
cluded: the Tuskegee Study where standard antibiotic treatment for 
syphilis was withheld, for a forty year period, from four hundred in-
fected black men and55 the Jewish Chronic Disease Hospital in Brook-
lyn where patients suffering from chronic debilitating conditions were 
involuntarily injected with live cancer cells as part of a cell rejection-
rate study.56 The dominant approach to research ethics, which is re-
flected in the Tri-Council Policy Statement and the earlier MRC Guide-
lines, primarily aims to curb abuses like these where people are deliber-
ately misled or involuntarily recruited to serve as research subjects. To 
this end, mainstream research ethics emphasizes the fundamental value 
of individual rights to autonomy, dignity, and bodily integrity. 
Feminist bioethicists concur that all individuals must be free to 
refuse to participate as research subjects and that the potential hanns 
should not outweigh the potential benefits of agreeing to participate. 
However, feminists diverge from traditional bioethics literature, when 
they draw attention to the gender dynamics inherent in both the underly-
ing theory and the patterns that emerge through practical adherence to 
the mainstream principles. The principle of autonomy, for instance, is 
generally thought of in a highly individualistic manner, focussing 
mainly on the potential research subject's relative freedom to refuse to 
participate as a research subject. This approach effectively removes 
from consideration the social context which influences how potential 
participants exercise their power to choose. "Rather than just asking 
whether research subjects truly understand all relevant details about 
their involvement (a question we still consider important), we argue that 
questions must also be asked about who is invited to participate and who 
54 S. Harding, Whose Science? Whose Knoivledge? (Ithaca, N.Y.: Cornell University, 
1991) at 204. 
55 S. Sherwin, No Longer Patient: Feminist Ethics and Health Care (Philadelphia: Temple 
University, 1992) at 162-163 [hereinafter No Longer Patient]. 
56 Ibid. 
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is not and how the specific research questions were selected."57 True to 
the form of its predecessors, the Tri-Council Policy Statement ignores 
these kinds of questions and retains the traditional emphasis on indi-
vidual liberty rights. 
The Tri-Council Policy Statement indicates in commentary passages 
that "[ w ]hether intentional or inadvertent, the exclusion of some from 
, the benefits of research violates the commitment to societal justice."58 It 
continues to state that "distributive justice imposes on researchers and 
REBs a duty not to act in a discriminating fashion."59 Unfortunately, 
neither of these important principles is reflected in the fonnal Articles 
that follow. 
Under the heading "Research Involving Women", the Tri-Council 
Policy Statement provides one simple Aliicle: "Women shall not auto-
matically be excluded from research solely on the basis of sex or 
reproductive capacity."60 The accompanying narrative states some im-
p01iant principles but gives little in the way of concrete direction to REB 
members who may be struggling with the exclusion criteria in a particu-
lar research protocol. 
Clearly, the Tri-Council Policy Statement is ill-equipped to assist 
REB members who make the ultimate decisions on issues relating to the 
inclusion of women in research. Given that this statement is the major 
source of rules for researchers operating with grants from CIHR, 
SSHRC, and NSERC, Canada's largest public research funding agen-
cies, its inadequacy is staggering. One cannot avoid concluding that the 
Tri-Council Policy Statement is complicit with the medical 
establishment's traditional bias towards men's interests over women's 
interests in health and broader social equality. 
57 S. She1win, "A Relational Approach to Autonomy in Health Care" in Exploring Agency 
and Autonomy, supra note I at 39-40. 
58 Tri-Council Policy Statement, supra note 41 at 5.2. 
59 Tri-Council Policy Statement, supra note 41. 
60 Tri-Council Policy Statement, supra note 41 at 5.3. 
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IV. FEMINIST ANALYSIS OF JUSTIFICATIONS FOR 
THE EXCLUSIONARY NORM 
Proponents of the traditional status quo in research generally raise 
four justifications when forced to defend practices that marginalize 
women. These are the need for scientific rigour and gender uniform data, 
prohibitive monetary expense, fetal protection and avoidance of poten-
tial liability. However these arguments favouring maintenance of the 
exclusionary status quo reveal the persistence of deeply and dangerously 
traditional views of women. None of these justifications for exclusion-
ary research practices is tenable from a feminist perspective. These 
excuses do not reflect an interest in the promotion of women's health but 
rather in protecting the particular interests of the medical research 
establishment. 
1. Locating the Roots of the Exclusionary Phenomenon 
One explanation for the persistence of the liability-avoidance excuse 
is gender-biased misunderstanding of the informed consent doctrine 
within the research community. Justice Ellen Picard has observed that in 
the 1980s and 1990s, examples could still be found in Canada where 
doctors and hospitals refused to accept the consent of a woman to 
medical treatment, clinging to the belief that women and girls could not 
provide valid consent and that husbands and fathers were the more 
legitimate decision-makers.61 The underlying issue is general equivoca-
tion around women's autonomy rights and capacity to make reasoned 
healthcare decisions. This has been particularly evident in abortion 
debates. 
In the 1989 case Tremblay v. Daigle, 62 the Supreme Court of Canada 
overturned a lower court's injunction which prohibited a woman from 
obtaining an abortion on the grounds that her former common law 
partner objected. The Quebec Court of Appeal trivialized Ms. Daigle's 
reasons for seeking to te1minate the pregnancy and devalued the harms 
she believed would result to her if the pregnancy were can-ied to term. 63 
61 E. Picard & G. Robertson, Legal Liability of Doctors and Hospitals in Canada, 3d ed. 
(Scarborough, Ont.: Carswell, 1996) 60. 
62 [ 1989] 2 S.C.R. 530. 
63 Martin, supra note 3 at 305. 
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On appeal, the Supreme Court rejected this reasoning and held that a 
potential father does not hold a legal right to veto a woman's decision to 
tenninate pregnancy. As this judgement clearly indicates, there is no 
legal requirement for medical professionals to seek consent from a 
woman's spouse or any other person prior to commencing any medical 
intervention. Uncertainty about the validity of autonomous consent by 
women to participate as medical research subjects may nonetheless 
continue to linger, particularly where researchers have a strongly pater-
nalistic orientation towards potential fetuses. 
The distmst shown by both legal and medical institutions in Canada 
in the ability of women to make autonomous decisions about their 
reproductive capacity, and their health more broadly, suggests outdated 
views of women as essentially non-rational beings who should be di-
vested of power to control their bodies. 
Exclusionary research practices may also reflect the idea that re-
searchers and research funders attach priority to the health issues that 
they personally fear. 64 Given that researchers and those who make 
funding decisions have historically been men, the lack of attention 
directed to women's health (with the exception of women's reproduc-
tive capacities) makes sense. This is reinforced by the system of research 
funding. "Researchers do not pursue whatever projects come into their 
heads but those for which they can receive funding. Needing to attract 
grant money and produce results, they shape their research interests to 
serve the orientations of funding sources."65 From this perspective, 
where key decision-makers are predominantly white, upper to middle 
class men, the research agenda can be expected to reflect the interests of 
that social group.66 
It is worth noting that while the number of women in the medical 
profession has grown considerably in Canada, women continue to hold 
fewer leadership positions than men do. Institutional priorities can 
subsequently still be seen as stmctured around gendered concepts de-
spite the influx of women. 
6-1 Melion, supra note 34 at 373 cites US Congressional Representative Patricia Schroeder 
as saying, "[Y]ou fund what you fear. When you have a male-dominated group of researchers, 
they are more won-ied about prostate cancer than breast cancer." 
65 Sherwin, No Longer Patient, supra, note 56 at 17. 
66 Fox, supra, note 48 at 126; S. Rosser, "Gender Bias in Clinical Research: the Difference 
it Makes" in Refiwning Women's Health, supra note 11. 
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Probably of more fundamental importance than the sheer number of 
women in medicine and research, however, is the dominance of scien-
tific research methods that pose as gender-neutral while contributing to 
highly gendered health implications. One group of feminists writes: 
Science is not a value-neuh·al activity in practice, nor should it aspire 
to be. The demands of disinterestedness do promote, not better sci-
ence, but rather science that preferentially serves some interests and 
neglects others by blocking efforts to expose that fact by denying and 
thereby hiding the interests that are operative. When the determinate 
interests are those of the dominant group(s) in society, they seem to be 
both natural and general since they blend seamlessly with the cultural 
dominance of those groups in all spheres of activity. It is only when the 
particular interests of marginalized groups (i.e., those who are subject 
to oppression) that appear to be 'special interests' that threaten to 
contaminate otherwise 'pure' scientific methods.67 
This line of argument is a strong departure from the long-held view 
of scientific researchers as objective, value-neutral investigators. 68 
Feminist standpoint theorists contend that knowledge, which represents 
the sum of a society's opinions and best beliefs, is unequivocally a 
socially-grounded phenomenon. Accordingly, knowledge-generators 
are seen as heavily influenced by the dominant social constructs of the 
milieu in which they function. 69 While this view of the role of the 
researcher is generally accepted in the social science disciplines, it is 
met with significant resistance from quaiiers of the research community 
that associate themselves with the so-called 'hard' or 'pure' positivistic 
fields. Thus, researchers identifying with the classic biomedical disease 
model of health are usually highly skeptical of feminist epistemological 
theory and extremely critical of the notion of a researcher as an active 
participant who influences the results of the research process. 
In a revealing parallel, similar lines of debate are often heard within 
Caiiada' s legal community regarding the adjudicative function. Since 
the 1970s, feminists have been instrumental in challenging the long-held 
view of the judge as a truly neutral arbiter. 70 While the standpoint 
approach to knowledge-as-truth and the use of knowledge in decision-
67 Baylis, Downie & Sherwin, supra note 33 at 237. 
68 Supra note 33 at 236. 
69 Harding, supra note 55 at 302-303. 
70 N. Wikler, "Identifying and Correcting Judicial Gender Bias" in S. Martin & K. 
Mahoney, eds., Equality and Judicial Neutrality (Calgary: Carswell, 1987) at 254. 
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making has gained a certain level of credence on a theoretical level, 
there is marked discord over the practical implications of taking this 
jurisprudential approach. 
The Supreme Court of Canada's four-way split decision in the 1997 
case R. v. R.D.S. 71 reflects the enormous degree of controversy sur-
rounding the issue of socially contextualized decision-making on the 
bench. Accepting that judges must often incorporate untested presump-
tions about human and societal nature when making decisions, the 
contested issue today seems to be the extent to which (if any) these 
presumptions should be recognized and enunciated in a judge's fonnal 
reasons. Proponents of the traditional approach suggest that sphinx-like 
posturing is necessary and appropriate in many circumstances in order 
to avoid needless controversy which may bring the administration of 
justice into disrepute.72 This suggestion completely side-steps the argu-
ment that it is the status quo approach itself which has brought the 
administration of justice into disrepute and led to views of the system as 
catering mainly to the political and economic interests of dominant 
social groups. According to critical race theorist Carol Aylward, judicial 
silence about social context presumptions permits an unacceptable lack 
of accountability. Silence disallows opportunity to guard against reli-
ance on myths and prejudicial beliefs infecting the decision-making 
process.73 
While Canadian legal commentators agree that unproven social 
context assumptions play a meaningful role in decision-making, there 
appears to be no agreement on the question of whether the administra-
tion of justice will be improved or compromised if judges are more 
explicit in sharing their untested views of social truth in the course of 
rendering decisions. In contrast, decision-makers in biomedical research 
seem less inclined to accept, even on a theoretical level, standpoint-
based epistemological arguments about the relationship between social 
context and choices exercised in the course of research. While certain 
progress has been made in this area, particularly by women in the 
research field, 74 mainstream medical researchers and institutions have 
71 [1997] 3 S.C.R. 484. 
72 B. Archibald, "The Lessons of the Sphinx: A voiding Apprehensions of Bias in a Multi-
racial, Multi-cultmal Society" 10 C.R. (5t11) 54. 
73 "'Take the Long Way Home': R.D.S. and Critical Race Theory" 41 U.N.B.L.J. 61. 
74 Harding, supra note 55 at 296-312. 
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not yet opened enough to enable feminist reframing of the knowledge-
generating enterprise. 
The purpose of this discussion has been to show that general notions 
of what constitutes 'good' decision-making in both the judicial realm 
and the realm of biomedical research place significant emphasis upon 
the role filled by individuals in key positions of authority. Feminists and 
other critical theorists have demonstrated that the long-prevailing view 
of decision-makers in both realms as purely objective and politically 
neutral is itself an inherently ideological position. By exposing this 
central fallacy, the notion of 'good' decision-making becomes contest-
able and the results of supposedly 'good' decisions can be more criti-
cally assessed. 
v. ACTION FOR CHANGE 
The women's health movement and its calls for more inclusive 
research practices have made an unmistakable impact upon federal 
health policy in Canada. As this section will show, however, it is 
uncertain whether the successes won through political channels will 
result in meaningful change at the substantive level, where basic deci-
sions about funding and research protocol design are made. 
The international women's health movement has grassroots origins, 
ste1mning from radical feminists' efforts in the 1970s to encourage 
women to reclaim the knowledge and ownership of their bodies. Part of 
the broader women's equality movement, the women's health agenda 
has moved from its initial fringe position to a central, highly visible one 
and has gained wide public support over the past two decades. 
Bernadine Healy, a fonner Director of the U.S. National Institutes for 
Health, reflects this transition when she states "[i]t is not 'politically 
correct,' nor is it radically feminist, to suggest that disease prevention is 
critical to the public health of all Americans; it is common sense."75 
Nonetheless, the reality that mainstream medicine has not fully em-
braced the feminist agenda is reflected in the title of Healy' s book: A 
75 Supra note 14 at 15. 
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New Prescription/or Women's Health; Getting the Best Medical Care 
in a Man's World. 76 
The starting point for Canadian government recognition of women's 
health and research as distinctly important public policy issues was the 
1985 Third World Conference on Women in Nairobi. 77 In 1988 the 
Department of Health and Status of Women Canada sponsored a na-
tional symposium on women's health which led to the creation of a 
pennanent Federal/Provincial/Territorial Working Group on Women's 
Health to advise the Conference of Deputy Ministers of Health. Publica-
tion of the Working Group's first report in 1990 coincided with a period 
of intense lobbying of Canadian and American governments by women 
with breast cancer.78 A House of Commons Standing Committee on 
Breast Cancer was established in response and increased government 
funding for breast cancer research followed shortly thereafter. In 1993 
the National Fornm on Breast Cancer research brought together an 
unconventional mix of researchers, women with breast cancer, cancer 
agency volunteers, physicians, and government policy workers and 
demonstrated a high-level commitment to promoting fonns of research-
ing women's health that extend well beyond the biomedical sphere. 
Contributing to improved knowledge about women's health was a 
component of the Liberal Party's 1992 election platform and the govern-
ment has followed through with many of its promises in this regard. A 
Women's Health Bureau was established at Health Canada in 1993, and 
in 1996 Ottawa provided funding to establish five national Centres of 
Excellence for Women's Health (CEWH). The CEWH Program has a 
six-year lifespan and will provide $2 million ammally to each of the five 
Centres during this period. The ultimate objective of the Program" ... is 
to improve the health status of Canadian women by enhancing the health 
system's understanding of, and responsiveness to, women's health is-
sues. The work conducted by the funded Centres will be policy-oriented 
and aimed, ultimately, at making necessary changes to the health sys-
tem."79 Narrowing the knowledge gap between gender and the other 
76 Supra note 14. 
77 Supra note 11 at 2. 
78 Supra note 11 at 2. 
79 Health Canada, Centres of Excellence for Women's Health Program (January 1997) fact 
sheet prepared for the Canada-U.S.A. Women's Health Forum. 
WOMEN'S HEALTH RESEARCH ... 205 
detenninants of health is seen as critical to accomplishing these general 
aims. 
Health Canada's Women's Health Strategy is the most recent federal 
government statement of its commitment to improving women's health 
and usage of the health detenninants model in research and policy-
making. 80 Among other things, the Women's Health Strategy directly 
addresses the need to promote more and better inquires into women's 
health across the research spectrum. Health Canada pledges to make the 
research programs and activities it supports " ... more relevant to 
women's health concerns."81 The CEWH Program is featured promi-
nently in the subsequent statements of intention. Whether or not the 
CEWH Program is capable of facilitating change of such magnitude in 
the research realm remains to be seen. Prospects do not appear good, 
however, given that the Program is designed to be short-lived, and that 
the allocated funding is minute relative to the total federal investment in 
health research ($10 million annually versus the $500 million the gov-
ernment has pledged to spend from 1999 to 2002). The Women's Health 
Strategy further states that additional federal monies will be made 
available to support high priority women's health issues. No figures are 
provided, however, so the extent of this support is unknown. 82 
The Strategy document also makes reference to Health Canada's 
relatively new Guidelines on Inclusion of Women in Clinical Trials. 83 
The Strategy promises that this policy " ... will be monitored."84 A 
medical doctor on staff at Health Canada's Therapeutic Products 
Programme (which is responsible for implementing the inclusion 
policy) provides the following insight: "To be frank and brutally honest, 
while we, the civil servants, are interested in . . . finding out if there are 
differences between males and females [in responses to new drugs 
studied in clinical trials] ... we all wonder if push came to shove whether 
our government would stand up to the companies to require this."85 
80 Health Canada (Women's Health Bureau), Women's Health Strategy (Ottawa: Health 
Canada, 1999). 
81 Ibid. at 9. 
82 Supra note 82. Priority areas noted include: the causes of breast cancer including 
environmental concerns; chronic illnesses; mental health, including self-esteem of the girl 
child; and barriers to the utilization of services such as diversity and socio-economic issues. 
83 See description of the Women in Clinical Trials Guidelines above. 
84 Health Canada, supra note 82 at 4. 
85 Supra note 32. 
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This indication of resistance to the policy by the private sector and 
the government's corresponding unwillingness to move from "guide-
lines" to more coercive measures is revealing. It suggests that, to a 
certain degree, the government's oft-avowed commitment to women's 
health and an equitable research agenda is mere posturing. The Cana-
dian Women's Health Network (CWHN) is one activist group that has 
called on the federal government to intervene more directly to demon-
strate that this pessimistic scenario does not reflect reality. 
In its February 1999 budget the government announced plans to 
significantly increase research funding and to change the organizational 
structure of public funding for health research. Aiming to promote a 
more collaborative Canadian research sector, the government indicated 
its intention to merge health research funding into a single entity called 
the Canadian Institutes for Health Research (CIHR). The MRC was 
replaced by CIHR and health research funding is no longer distributed 
through SSHRC and NSERC. Enabling legislation was passed on No-
vember 4, 1999. The new organization was functional by April 1, 2000 
and includes an Institute for Gender and Health (one of thirteen Insti-
tutes). Promotion of women's health does not appear to be an express 
theme within the CIHR structure. 
A CWHN working group was active from the outset in pressing 
CIHR's government-appointed Interim Governing Council to ensure 
that women's health interests would be reflected in the new structure.86 
Among other specific measures, the working group recommended that 
the government create legislation mandating the inclusion of women, 
children, and minorities in CIHR-funded research activities. 87 The 
CWHN working group was seeking legislative intervention modeled on 
a U.S. federal statute, the 1993 National Institutes of Health Revitaliza-
tion Act. 88 This Act directed the National Institutes of Health (NIH), a 
federal research funding body with structures similar to the new CIHR, 
to establish guidelines for the inclusion of women and mino1ities in 
86 The CWHN working group operates with coordination and secretariate support from the 
Women's Health Bureau at Health Canada. An interdisciplinary group, it includes academic 
and community-based researchers, health policy workers, medical researchers and practitio-
ners. For further information see online: Canadian Women's Health Network <http:// 
www.cwhn.ca> (date accessed: November 7, 1999). 
87 Ibid. See "Communique #2" October 1999. 
88 Pub. L. No. 103-43. 
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clinical research. Giving effect to the federal Act, the NIH released 
extensive guidelines in 1994 and established the clear policy that NIH 
research awards would hinge upon confonnance with the Guidelines.89 
The NIH Guidelines and the companion piece, an 81-page Outreach 
Notebook, present a detailed and forceful contrast to the vague statement 
from Canada's Tri-Council that "women shall not automatically be 
excluded from research solely on the basis of sex or reproductive 
capacity."90 Moreover, it is far more broadly applicable than Health 
Canada's Guidelines on Inclusion of Women in Clinical Trials. 91 
It is unlikely such legislative intervention will transpire in Canada in 
the near future given the federal government's 'hands-off' policy ap-
proach to the regulation of research involving humans. The Medical 
Research Council has consistently advocated against legislation, argu-
ing, among other things that guidelines are more flexible than laws and 
thus more adaptable to shifting a social consensus of acceptable 
norms.92 The Tri-Council has taken a similar stance: 
.. .legal and ethical approaches may lead to different conclusions. The 
law tends to compel obedience to behavioural norms. Ethics aim to 
promote high standards of behaviour through awareness of values, 
which may develop with practice and which may have to accommo-
date choice and liability to en. Further, though ethical approaches 
cannot preempt the application of law, they may well affect its future 
development or deal with situations beyond the scope of the law. 93 
Given the inadequacy of the Tri-Council's statement with respect to 
inclusion of women in research, and the general criticisms about the 
effectiveness of the fragmented model of accountability at present, the 
research community does not seem poised to make the types of progres-
sive changes called for by the feminist critique. In light of the deep roots 
of gender bias in the history of medical science, and the bias which 
continues to exist in society more generally, it does not seem reasonable 
to expect that the research community will voluntarily dispose of its 
89 NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical 
Research, 59 FR 11146 at Ill.C. 
90 Tri-Council Policy Statement, supra note 41 at Art. 5.2. 
91 Supra note 20. 
92 Medical Research Com1cil, Guidelines on Research Involving Human Subjects (Ottawa, 
Ont.: Agency, 1987) at 11. 
93 Supra note 20 at i.8. 
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traditional exclusionary practices. Subsequently, as the government has 
repeatedly expressed commitment to advancing women's health 
through research, it seems that more meaningful action is required than 
what has occurred thus far. 
VI. CONCLUSION 
The women's health movement has had some political success in 
Canada. This is reflected in the establishment of a Women's Health 
Bureau at Health Canada, funding for women-centred research pro-
grams, and the implementation of an inclusionary clinical trials policy in 
the area of new drug submissions. At the same time, however, the extent 
of conceivable social change within the existing regulatory framework 
of law and ethics is very limited. Federal legislative intervention, which 
would be consistent with the numerous international pledges made by 
the Canadian government to advance the women's health agenda, may 
prove to be the most viable route to facilitating substantive change at the 
level where the bulk of research decision-making occurs. Intensive 
public lobbying is needed to ensure Ottawa resists simply accepting the 
agenda of the entrenched, deep-pocketed research community. 
